top of page

Search Results

Results found for "positive allosteric modulators"

  • Artificial intelligence – faster, smarter, cheaper GPCR drug discovery

    vs Deep Learning GPCRs have long been recognized as important drug targets, and numerous drugs that modulate ML algorithms typically use traditional ML models, such as decision trees and support vector machines which comprise handcrafted features and simpler models. For this reason, DL models generally require more computational resources (such as powerful GPUs) and sites (orthosteric, allosteric), activation mechanisms, and conformational changes. 8.

  • 📰 GPCR Weekly News, February 20 to 26, 2023

    Allosteric modulation of conserved motifs and helices in 5HT2BR: Advances drug discovery and therapeutic

  • 📰 GPCR Weekly News, August 28 to September 3, 2023

    GPCR Symposium on 'GPCRs as Therapeutic Modalities' Showcase your project with a 1-minute abstract video Discovery On Target September 27 - 28, 2023 | Training Seminar "The Renaissance in GPCRs as Drug Targets: Allosteric

  • 📰 GPCR Weekly News - January 2 to 8, 2023

    Updates in GPCR Research Small Molecule Tools to Study Cellular Target Engagement for the Intracellular Allosteric

  • Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!

    Senior Scientist/Staff Scientist, Computational Chemistry Postdoc in GPCR mechanosensing   Postdoctoral Position antagonist Probing the energy landscape of the lipid interactions of the serotonin1A receptor Potential allosteric

  • Regulation of pulmonary surfactant by the adhesion GPCR GPR116/ADGRF5 requires a tethered agonist...

    ) that mediate stronger signaling in mouse versus human GPR116 and recapitulate these findings in a model

  • β2-Adrenergic Receptor Expression and Intracellular Signaling in B Cells Are Highly Dynamic during..

    September 2022 β2-Adrenergic Receptor Expression and Intracellular Signaling in B Cells Are Highly Dynamic during Collagen-Induced Arthritis "The sympathetic nervous system (SNS) has either a pro-inflammatory or anti-inflammatory effect, depending on the stage of arthritis. In the past, treatment of arthritic B cells with a β2-adrenergic receptor (β2-ADR) agonist has been shown to attenuate arthritis. In this study, the expression and signaling of β2-ADR in B cells during collagen-induced arthritis (CIA) were investigated to provide an explanation of why only B cells from arthritic mice are able to improve CIA. Splenic B cells were isolated via magnetic-activated cell sorting (MACS). Adrenergic receptors on B cells and intracellular β2-ADR downstream molecules (G protein-coupled receptor kinase 2 (GRK-2), β-Arrestin 2, p38 MAPK, extracellular signal-regulated kinase 1/2 (ERK1/2) and cAMP response element-binding protein (CREB)) were analyzed at different time points in naïve and arthritic B cells with and without stimulation of β2-ADR agonist terbutaline by flow cytometry. β2-ADR-expressing B cells increase during CIA without a change in receptor density. Moreover, we observed a profound downregulation of GRK-2 shortly after induction of arthritis and an increase in β-Arrestin 2 only at late stage of arthritis. The second messengers studied (p38, ERK1/2 and CREB) followed a biphasic course, characterized by a reduction at onset and an increase in established arthritis. Stimulation of CIA B cells with the β-ADR agonist terbutaline increased pp38 MAPK independent of the timepoint, while pERK1/2 and pCREB were enhanced only in the late phase of arthritis. The phosphorylation of p38 MAPK, ERK1/2 and CREB in the late phase of arthritis was associated with increased IL-10 produced by B10 cells. The change of β2-ADR expression and signaling during sustained inflammation might be an integral part of the switch from pro- to anti-inflammatory action of sympathetic mechanisms in late arthritis." Read more at the source #DrGPCR #GPCR #IndustryNews

  • 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)

    β-arrestin-1 revealed by 19F NMR spectroscopy Role of protease activated receptor 4 (PAR4) in mouse models proliferation of T-cell lymphoma cells through the enhancement of apoptosis Methods & Updates in GPCR Research Modulating Fully activated structure of the sterol-bound Smoothened GPCR-Gi protein complex Deep Learning Dynamic Allostery oncology biomarker expert NEW Postdoctoral Fellow NEW Scientific Assistant Scientist Lead Researcher Post-Doctoral Fellow Sr Scientist in Obesity, Muscle, and Metabolism Post-Doctoral Fellow Explore Dr.

  • Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon

    Learn binding, bias, kinetics, and core models—fundamentals that fuel confidence and fluency Move beyond apply selectivity, ADME, and early safety in real development contexts Advance with nuanced lessons on allostery This blog post breaks down Dr.

  • 📰 GPCR Weekly News, March 6 to 12, 2023

    Neuroscience Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson's disease mouse model Intermediate-state-trapped mutants pinpoint G protein-coupled receptor conformational allostery. Structural and Molecular Insights into GPCR Function Endogenous l- to d-amino acid residue isomerization modulates

  • GPCR Buzz of the Week | Sep 23 - 29, 2024

    Modules: October 31st : The Eyes to See- The Importance of Pharmacologic Assays. Senior Scientist/Staff Scientist, Computational Chemistry Postdoc in GPCR mechanosensing   Postdoctoral Position Postdoctoral research position Adhesion GPCRs The G Protein-Coupled Receptor GPR56 Is an Inhibitory Strategy to Enhance Azobenzene-Based Photopharmacology GPCRs in Cardiology, Endocrinology, and Taste Rap1A Modulates structure of human class C orphan GPCR GPR179 involved in visual processing Reliability of AlphaFold2 Models

  • The Quiet Power of RGS Proteins: Rethinking Pain Pathways through GPCR Biology

    Venetia Zachariou  introduced him to the power of RGS proteins — particularly RGS4  — in modulating pain recovery that is very rare to see at the preclinical level. " Such recovery is rare in preclinical pain models and hints that RGS proteins could modulate pain chronification itself .

  • Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery

    (Bikker et al., 1998) Quantitative studies of how drugs modulate their targets have been instrumental with novel specificity high-throughput selection, has been used to identify specificity-determining positions Integrating mutagenesis data with computational models also presents challenges, requiring high-quality allowing researchers to determine the functional consequences of every possible amino acid change at each position G-protein coupled receptors: models, mutagenesis, and drug design.

  • 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024

    Senior Scientist/Staff Scientist, Computational Chemistry Postdoc in GPCR mechanosensing   Postdoctoral Position Postdoctoral research position GPCR Activation and Signaling Germline mutations in a G protein identify signalling profiles GPCRs in Cardiology, Endocrinology, and Taste Cyclic adenosine monophosphate critically modulates of fingolimod (FTY720) and desensitization of S1P1 receptor-mediated G-protein activation in a mouse model Architecture and Positive Sample Machine Learning Strategies Reviews, GPCRs, and more GPCR Biosensors

  • 📰 GPCR Weekly News, April 22 to 28, 2024

    Our Chief Matchmaker, Mark Schmeizl, had a great conversation about this position with Beth Fleck, Director Signaling at the Endosome GPCR Binders, Drugs, and more Discovery and development of macrocyclic peptide modulators RNA NEAT1 in Alzheimer's disease Parenting behaviors in mice: Olfactory mechanisms and features in models Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026 GPCR Jobs NEW Post Doctoral Fellow Postdoc Position Principal Scientist, In vitro pharmacology Senior Associate Scientist

  • What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024

    or seek assistance GPCR Events to keep you informed and engaged GPCR Jobs connecting candidates with positions Domain Therapeutics Nominated for the Prestigious Best Startup Award Tectonic Therapeutic Announces Positive Scientist, Computational Chemistry GPCR Activation and Signaling Pathophysiological significance and modulation GPR56: GPCR as a guardian against ferroptosis Methods & Updates in GPCR Research Memprot.GPCR-ModSim: Modelling

  • Beyond the Probe: Scaling Innovation From the Bench to Product Launch

    Maria Majellaro Celtarys specializes in the custom development of fluorescent ligands  using a modular Their method allows researchers to explore different linker positions, tailor activity (agonist or antagonist GPCR ecosystem , Celtarys is opening up that model to the broader research community. The goal?

  • Overview of adhesion GPCRs self-activation

    Structurally they characterize by a long extracellular region of adhesion-like domains which modulate ADGRG2/GPR64, and ADGRG4/GPR112 were reported in their self-activating state, i.e. a unique activation model From a structural perspective, the -4 position of αH5 was key for the selectivity of G-protein coupling , since the change of amino acids in positions close to this position favored signaling toward a specific self-activation of aGPCRs and open new perspectives for the community to formulate strategies to help modulate

  • How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision

    Leadership-level roles in clinical operations and translational science, alongside multiple GPCR-focused postdoc positions Must-read publications:  A structural modeling study revealing non-canonical mechanisms of chemokine-driven From t-test, ANOVA, F-test selection to power analysis  that prevents underpowered studies, this module

  • Why Opposing Processes Matter for Your Next GPCR Drug

    in isolation—they respond to the system they’re in, often through opposing processes that you must model In this session, you’ll gain: ✅ A mental model you can trust  for predicting how GPCR ligands behave This section outlines the logic required to match preclinical models to patient physiology and avoid In this module, you’ll explore how some receptor–agonist complexes continue signaling from endosomes, Your molecule isn’t failing—your model might be too simple.

  • Drug Discovery Picks Up the Pace, Stays on Target

    They include small molecules that conditionally modulate proteins in their functional state; three-dimensional (3D) cell models, or organoid models, that assist with target identification, high-throughput drug screening

  • GRK2 in cardiovascular disease and its potential as a therapeutic target

    Additionally, GPCR dysregulation underlies multiple models of cardiac pathology, and most pharmacological Current literature strongly establishes increased levels and activity of GRK2 in multiple models of CVD the GRK2 interactome includes numerous proteins which interact with differential domains of GRK2 to modulate the ongoing and future research for targeting this critical kinase across cellular, animal and human models

  • 📰 GPCR Weekly News, June 26 to July 2, 2023

    Adhesion GPCRs A screen of pharmacologically active compounds to identify modulators of the Adgrg6/Gpr126 Modulation of GPCR receptors common to gut inflammatory diseases and neuronal disorders, Alzheimer's Internal and external modulation factors of the orexin system (REVIEW). Structure-based pharmacophore modeling 2. Developing a novel framework for structure-based pharmacophore model generation and selection.

  • 📰 GPCR Weekly News, November 20 to 26, 2023

    Domain Unfolding in Adhesion GPCRs Molecular Sensing in Adhesion GPCR Dissociation Physiological Force Modulation and interface interactions Experimental modulation of physiological force application on leg joint neurons Clinical Pharmacology 2026 GPCR Jobs - Contact Mark Schmeizl NEW Scientist NEW Lead Researcher NEW Post-Doctoral Fellow Sr Scientist in Obesity, Muscle, and Metabolism Post-Doctoral Fellow Research Associate I, Tissue Culture Post-Doc Research Associate Postdoctoral Fellow Explore Dr.

  • How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)

    on kinetic tools that reveal what steady-state data can’t—so you can vet leads faster, avoid false positives begins first-in-human trial of SEP-631 for CSU; Maxion’s KnotBody® platform; a new angle on RGS protein modulation redefining weight-management and diabetes markets—implications for GPCR-linked pathways and competitive positioning Must-read publications:  From on stabilizing RGS2 via modulating its degradation (versus direct inhibition

  • Inside Out: Mapping GPCRs from Membrane Codes to Market Moves

    Additionally, new studies reveal how phosphorylation barcodes shape arrestin engagement, a biased NTSR1 modulator Terry Kenakin, these five modules reveal how location bias, intracellular signaling, and ligand kinetics GRK-Specific Phosphorylation Barcodes Shape Arrestin Engagement with ACKR3   A β-Arrestin-2-Biased NTSR1 Modulator

  • From Technician to Trailblazer: How Sokhom Pin Designed His Own PhD Program While Working in Industry

    With a growing family and a full-time position, traditional PhD training just wasn’t an option. A Model for Future Scientists? His hybrid path is a model of possibility for professionals in the biotech industry who still dream of

  • Community guidelines for GPCR ligand bias: IUPHAR review 32

    August 2022 "GPCRs modulate a plethora of physiological processes and mediate the effects of one-third implementation of the guidelines, together improving translation from in vitro to disease-relevant in vivo models

  • Regulators of G-protein signaling: essential players in GPCR signaling

    are selective for certain GPCRs, as a proof RGS4 which is expressed in the brain, has been shown to modulate RGS4 is expressed in various immune cells, including T cells and B cells, and has been shown to modulate In conclusion, RGS proteins are essential modulators for the GPCR signaling mediated by G proteins, which Hepler, Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Traynor, Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein

  • Glyco-sulfo hotspots in the chemokine receptor system

    modifications (PTMs), contribute to the high affinity binding to the positively charged groove on the chemokines through the charge interactions between the negative sulfate groups in the N-terminus and the positively Probing the modulation of O-glycosylation and tyrosine sulfation on CCR5 and CCR1 function In this study mutagenesis approaches were performed to evaluate the effects of O-glycosylation and tyrosine sulfation modulation It remains to be discovered how much the modulation of these PTMs is relevant for future drug design.

bottom of page